Combination of nivolumab with radiotherapy for non-small cell lung cancer

被引：0

作者：

Cihan, Y. B. ^{[1
,2
]}

机构：

[1] Kayseri City Educ & Res Hosp, Dept Radiat Oncol, Kayseri, Turkey

[2] Kayseri City Educ & Res Hosp, Dept Radiat Oncol, Ataturk Blvd,Hastane St 78, TR-38010 Kayseri, Turkey

来源：

ARCHIVES OF HELLENIC MEDICINE | 2022年 / 39卷 / 06期

关键词：

Nivolumab; Non-small cell lung cancer; Radio-therapy;

D O I：

暂无

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

引用

页码：857 / 858

页数：2

共 8 条

[1] Nivolumab versus Docetaxel in Advanced Squamous-Cell Non-Small-Cell Lung Cancer [J].

Brahmer, Julie ;

Reckamp, Karen L. ;

Baas, Paul ;

Crino, Lucio ;

Eberhardt, Wilfried E. E. ;

Poddubskaya, Elena ;

Antonia, Scott ;

Pluzanski, Adam ;

Vokes, Everett E. ;

Holgado, Esther ;

Waterhouse, David ;

Ready, Neal ;

Gainor, Justin ;

Aren Frontera, Osvaldo ;

Havel, Libor ;

Steins, Martin ;

Garassino, Marina C. ;

Aerts, Joachim G. ;

Domine, Manuel ;

Paz-Ares, Luis ;

Reck, Martin ;

Baudelet, Christine ;

Harbison, Christopher T. ;

Lestini, Brian ;

Spigel, David R. .

NEW ENGLAND JOURNAL OF MEDICINE, 2015, 373 (02) :123-135

[2] Immune Checkpoint Inhibitor Nivolumab and Radiotherapy in Pretreated Lung Cancer Patients Efficacy and Safety of Combination [J].

Fiorica, Francesco ;

Belluomini, Lorenzo ;

Stefanelli, Antonio ;

Santini, Alessandra ;

Urbini, Benedetta ;

Giorgi, Carlotta ;

Frassoldati, Antonio .

AMERICAN JOURNAL OF CLINICAL ONCOLOGY-CANCER CLINICAL TRIALS, 2018, 41 (11) :1101-1105

[3]

Ichiki Yoshinobu, 2017, Journal of UOEH, V39, P291, DOI 10.7888/juoeh.39.291

[4] Nivolumab: A Review in Advanced Squamous Non-Small Cell Lung Cancer [J].

Keating, Gillian M. .

DRUGS, 2015, 75 (16) :1925-1934

[5] Safety of combined PD-1 pathway inhibition and radiation therapy for non-small-cell lung cancer: A multicentric retrospective study from the GFPC [J].

Lesueur, Paul ;

Escande, Alexandre ;

Thariat, Juliette ;

Vauleon, Enora ;

Monnet, Isabelle ;

Cortot, Alexis ;

Lerouge, Delphine ;

Danhier, Serge ;

Do, Pascal ;

Dubos-Arvis, Catherine ;

Chouaid, Christos ;

Gervais, Radj .

CANCER MEDICINE, 2018, 7 (11) :5505-5513

[6] Nivolumab and stereotactic radiation therapy for the treatment of patients with Stage IV non-small-cell lung cancer [J].

Miyamoto, Shingo ;

Nomura, Ryutaro ;

Sato, Kengo ;

Awano, Nobuyasu ;

Kuse, Naoyuki ;

Inomata, Minoru ;

Izumo, Takehiro ;

Terada, Yuriko ;

Furuhata, Yoshiaki ;

Bae, Yuan ;

Kunitoh, Hideo .

JAPANESE JOURNAL OF CLINICAL ONCOLOGY, 2019, 49 (02) :160-164

[7] Safety of combining thoracic radiation therapy with concurrent versus sequential immune checkpoint inhibition [J].

von Reibnitz, Donata ;

Chaft, Jamie E. ;

Wu, Abraham J. ;

Samstein, Robert ;

Hellmann, Matthew D. ;

Plodkowski, Andrew J. ;

Zhang, Zhigang ;

Shi, Weiji ;

Dick-Godfrey, Rosalind ;

Panchoo, Kelly H. ;

Barker, Christopher A. ;

Rimner, Andreas .

ADVANCES IN RADIATION ONCOLOGY, 2018, 3 (03) :391-398

[8] Immune checkpoint inhibitors in non-small-cell lung cancer: current status and future directions [J].

Yan, Ya-fei ;

Zheng, Yong-fa ;

Ming, Ping-po ;

Deng, Xiao-xi ;

Ge, Wei ;

Wu, Yao-gui .

BRIEFINGS IN FUNCTIONAL GENOMICS, 2019, 18 (02) :147-156

← 1 →